Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: poodle who wrote (877)	1/24/1998 10:03:00 AM
From: Haolin Ni	Read Replies (1) \| Respond to of 3579

Please compare the press releases of GERN in 3/24/1997 and 12/22/1997. GERN reported $58 million collabration agreement with Pharmacia & upjohn, so the stock price was up about three points, which is the first obvious up movment of its stock price in 1997. The press release in 12/22/1997 had only empty words and no money was mentioned. The total assets of GERN was $31 million in July but only $25 million in Nov. 10Q. The assets reduction is about $6 millions in that quarter instead only $2.2 million lose in operation expenses. Kyowa Hakko provided about $1.5 million quarterly (this money will gone from April, 1998) and Pharmacia & Upjohn provides $1.25 million quarterly.